MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors

MET Expression in Primary and Metastatic Clear Cell Renal Cell Carcinoma: Implications of Correlative Biomarker Assessment to MET Pathway Inhibitors

Aims. Inhibitors of the MET pathway hold promise in the treatment for metastatic kidney cancer. Assessment of predictive biomarkers may be necessary for appropriate patient selection. Understanding MET expression in metastases and the correlation to the primary site is important, as distant tissue...

Full description

Bibliographic Details
Main Authors: Shuch, Brian, Falbo, Ryan, Parisi, Fabio, Adeniran, Adebowale, Kluger, Yuval, Kluger, Harriet M., Jilaveanu, Lucia B.
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2015
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584049/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4584049/

Similar Items